ISSN: 1387-2877
Journal Home
Journal Guideline
Journal of Alzheimer's Disease Q1 Unclaimed
Journal of Alzheimer's Disease is a journal indexed in SJR in Medicine (miscellaneous) and Neuroscience (miscellaneous) with an H index of 151. It has an SJR impact factor of 1.225 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.225.
Journal of Alzheimer's Disease focuses its scope in these topics and keywords: alzheimer’s, disease, dementia, cognitive, impairment, mild, amyloid?, risk, patients, frontotemporal, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1.225
SJR Impact factor151
H Index877
Total Docs (Last Year)2253
Total Docs (3 years)49162
Total Refs10857
Total Cites (3 years)2239
Citable Docs (3 years)3.98
Cites/Doc (2 years)56.06
Ref/DocOther journals with similar parameters
Journal of Clinical Oncology Q1
Annals of Oncology Q1
Annual Review of Public Health Q1
The Lancet Global Health Q1
Nature Reviews Disease Primers Q1
Compare this journals
Aims and Scope
Best articles by citations
Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks
View moreGenome-Wide Association Study Identifies SLAMF1 Affecting the Rate of Memory Decline
View moreRisk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease
View moreBlood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease
View moreTime Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study
View moreEnriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia
View moreAmyloid-beta/Drug Interactions from Computer Simulations and Cell-Based Assays
View moreAge-Dependent Increment of Hydroxymethylation in the Brain Cortex in the Triple-Transgenic Mouse Model of Alzheimer's Disease
View moreThe Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L)
View moreAltered Neurotransmission Prior to Cognitive Decline in AbetaPP/PS1 Mice, a Model of Alzheimer's Disease
View moreSerum MHPG Strongly Predicts Conversion to Alzheimer's Disease in Behaviorally Characterized Subjects with Down Syndrome
View morePotential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study
View moreAVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders
View moreIncorporating biomarkers into clinical drug trials in Alzheimer's disease
View moreImproved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-beta Positron Emission Tomography
View moreAnalysis of Salivary Microbiome in Patients with Alzheimer's Disease
View moreAge-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model
View moreBehavioral and Neuropsychiatric Disorders in Alzheimer's Disease
View moreAlbumin-Blunted Deleterious Effect of Amyloid-beta by Preventing the Internalization of the Peptide into Neurons
View moreAlzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults
View moreAberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin
View moreAssociation between a-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI
View moreMachine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease
View moreEffect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models
View more
Comments